Cytyc CEO Scheduled to Present at Thomas Weisel Partners Healthcare Tailwinds Conference.Business Editors & Health/Medical Writers BOXBOROUGH, Mass.--(BW HealthWire)--April 25, 2002 Cytyc Corporation (Nasdaq: CYTC) today announced that Patrick J. Sullivan, chief executive officer, vice chairman, and chairman-elect, is scheduled to speak at the Thomas Weisel Partners Thomas Weisel Partners Group, Inc. (NASDAQ: TWPG), often shortened to just TWP or TWeisel, is a U.S. middle-market and growth focused investment banking firm based in San Francisco, California. Healthcare Tailwinds Conference at The Four Seasons Hotel in Boston on April 29 at 9:00 a.m. (Eastern). Mr. Sullivan will participate in a panel discussion entitled en·ti·tle tr.v. en·ti·tled, en·ti·tling, en·ti·tles 1. To give a name or title to. 2. To furnish with a right or claim to something: , "Will I Get Cancer, Do I Have Cancer and Who Will Pay?" A webcast of the presentation will be available to the public at the following link: http://www.veracast.com/webcasts/twp/healthcare-2002/53102214.cfm. After the webcast, a recording of the presentation will be available until May 7 on Cytyc's web site, www.cytyc.com, in the Investor Information section. Cytyc Corporation develops, manufactures and markets products for medical diagnostic applications primarily focused on women's health Women's Health Definition Women's health is the effect of gender on disease and health that encompasses a broad range of biological and psychosocial issues. . The ThinPrep(R) System consists of the ThinPrep(R) 2000 Processor, ThinPrep(R) 3000 Processor, and related reagents, filters, and other supplies. Cytyc is traded on The Nasdaq Stock Market Nasdaq stock market The first electronic stock market listing over 5000 companies. The Nasdaq stock market comprises two separate markets, namely the Nasdaq National Market, which trades large, active securities and the Nasdaq Smallcap Market that trades emerging growth companies. under the symbol "CYTC" and is a part of the S&P Midcap 400 Index and The Nasdaq-100 Index. Cytyc(R) and ThinPrep(R) are registered trademarks and ThinPrep(R) Pap Test Pap test, Pap smear, or Papanicolaou test (păp'ənē`kəlou), medical procedure used to detect cancer of the uterine cervix. (TM) is a trademark of Cytyc Corporation. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion